Soticlestat
Soticlestat (OV935) is a potent, selective, and orally bioavailable inhibitor of cholesterol 24-hydroxylase (CYP46A1) . It is a research compound for investigating epilepsy syndromes, with studies demonstrating activity in both in vitro enzymatic assays and in vivo rodent seizure models.
Product Specifications
CAS Number
1429505-03-2
Product Name Alternative
OV935, OV-935, OV 935, NMDA, inhibit, Inhibitor, epilepsy, cholesterol, CYPs, CYP46A1, Cytochrome P450, 24-hydroxylase, antiepileptic, Soticlestat, TAK935, TAK-935, TAK 935
Field of Research
Metabolism Research
Purity
99.79% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.71 mM) ; DMSO:100 mg/mL (267.77 mM)
Smiles
OC1 (Cc2ccccc2) CCN (CC1) C (=O) c1cccnc1-c1ccncc1
Molecular Formula
C23H23N3O2
Molecular Weight
373.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M2438-10A-ML650 100 µL
MMP25, CT (Matrix Metalloproteinase-25, MMP-25, Membrane-type Matrix Metalloproteinase 6, MT-MMP 6, MTMMP6, Membrane-type-6 Matrix Metalloproteinase, MT6-MMP, MT6MMP, Leukolysin, MMP20, MMPL1, MT6MMP) (MaxLight 650) discontinued
Sign In for Pricing
View Details 